Treating obesity with medicine Mouniaro (tirzepatide) is carried out under under constant medical supervision and is part of an integrated treatment aimed at improving weight and metabolic health in the long term.
The process starts with a medical consultationwhere your doctor assesses your weight, body mass index (BMI), comorbidities and previous weight loss attempts. Based on the overall medical picture, the doctor assesses whether Mounjaro treatment is appropriate and sets realistic and achievable goals with the patient.
After treatment is started, the medicine is used as once weekly subcutaneous injection. Treatment always starts with a lower dose, which is gradually increasesto allow the body to adapt and reduce the chance of side effects. At the same time, the patient is familiarised with the use of the injection and given instructions for safe and correct administration.
Mouniaro works by affecting the hormones that regulate hunger, satiety and metabolism. This gradually reduces appetite, makes meals smaller and keeps you fuller for longer. Over time, this leads to gradual and sustainable weight losswithout the feeling of constant hunger.
During treatment regular check-upswhere the doctor monitors the progress of weight loss, metabolic indicators and possible side effects. If necessary, the dose is adjusted or the treatment is supplemented with additional dietary and exercise guidelines.
An important part of the treatment is support with lifestyle changes. Mounjaro is not a substitute for healthy eating and exercise, but a tool that makes it easier to establish more sustainable habits and maintain the weight you have achieved in the long term.
Treatment with Mounjaro is usually long-termas obesity is a chronic condition. With regular monitoring and patient participation, treatment can significantly improve health status, reduce the risk of complications and contribute to better well-being and quality of life.